Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.962 USD | -0.07% | +19.27% | -52.87% |
Apr. 30 | Gritstone Bio, Inc. Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA Vaccine at ESCMID Global 2024 | CI |
Apr. 29 | Gritstone Bio, Inc. Announces Board Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.87% | 103M | |
-3.89% | 88.14B | |
+1.45% | 40.51B | |
-14.68% | 31.67B | |
+51.20% | 24.62B | |
-15.07% | 15.65B | |
-14.05% | 12.07B | |
-7.87% | 11.97B | |
-39.40% | 11.61B | |
+5.62% | 8.81B |
- Stock Market
- Equities
- GRTS Stock
- News Gritstone bio, Inc.
- Gritstone Bio Discloses Preliminary Progression-Free Survival Data From Colorectal Cancer Vaccine Trial; Shares Fall